Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Cleveland-based regenerative medicine company didn't indicate how many shares it plans to sell. Athersys said it plans to use proceeds from the offering for working capital and general corporate purposes.
The Cleveland-based regenerative medicine company didn't indicate how many shares it plans to sell. Athersys said it plans to use proceeds from the offering for working capital and general corporate purposes.
/PRNewswire/ -- The Acute Ischemic Stroke Therapeutics Market share is expected to increase by USD 1524.49 million from 2022 to 2027, with an accelerated CAGR...
25.10.2022 - Brings deep industry experience spanning financial and operational roles to support Company and its new strategic directionJERSEY CITY, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) - SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering ... Seite 1
/PRNewswire/ -- The stem cell umbilical cord blood (UCB) market has been segmented by end-user (pharmaceutical, research institutes, hospitals, and biobanks)...